interactive-biosoftware com) Primers and PCR conditions

interactive-biosoftware.com). Primers and PCR conditions

were shown in Table 2. Sequence data were analysed using Sequencher version 5.0 (Gene Codes Corporation, Ann Arbour, MI, USA). Mutations found in the patients were confirmed by direct sequencing of the genomic DNA using a set of primers and parameters according to their mutation sites. Identified mutations were confirmed by direct sequencing in the opposite direction. The available parents were also tested for the identified mutation by PCR-sequencing. The nucleotide position is in accordance with the WASP mRNA (Genbank Accession No. NM_000377). All patients had clinical features consistent with the classic WAS, including thrombocytopenia with small-sized platelets, recurrent infections and eczema. The patients’

age of onset ranged from 6 days to 8 months. Bleeding was the first manifestation in the majority of selleck cases (85.7%, 6/7 cases) in which bloody stool was the most frequent presenting symptoms (71.4%, 5/7 cases). One patient was initially presented with pneumonia and hepatosplenomegaly. Cytomegalovirus (CMV) infection was subsequently confirmed. Of all the patients with recurrent infections, pneumonia was the most commonly found (85.7%, 6/7 cases). Other infections included central nervous system infections, infective diarrhoea caused by Salmonella, otitis media, sepsis and perianal abscess. The patients’ clinical features are summarized in Table 1. Immunoglobulin selleckchem levels and lymphocyte subsets were evaluated in all patients (Table 3). Of these seven patients, higher IgE levels were detected in six (85.7%). Most however had normal IgG, IgA and IgM levels. A CD4/CD8 ratio < 1 was detected in three patients (42.9%). Two patients had a score of 5 as they developed autoimmune haemolytic anaemia (AIHA) at the age of 7 years (case 1) and 1 year and a half (case 6). Regular intravenous immunoglobulin (IVIG) with a dose of 400 mg/kg/month was given to all patients. None underwent splenectomy.

Two (cases 2 and 4) received HSCT at the age of Chlormezanone 1 year and 4 months and 2 years and 5 months, respectively. The stem cell source was bone marrow from unrelated cord blood (case 2) or an HLA-matched sibling (case 4). Both had normal platelet counts within 2 months after HSCT and were alive. Of the patients without HSCT, one died at the age of 4 years due to intracerebral bleeding. Cytomegalovirus infection was found in one patient (case 7) who presented with tachypnea at 2 months of age. He was the first child and born at term to nonconsanguineous parents after an uneventful pregnancy and delivery. His birth weight was 2970 g with head circumference of 30 cm (< 3rd centile). At the age of 2 months, his weight was 3220 g (< 3rd centile) with a length of 52 cm (< 3rd centile) and head circumference of 33 cm (< 3rd centile). He was moderately pale without petechiae.

Comments are closed.